Logo Logo
Help
Contact
Switch Language to German

Ridderbusch, Isabelle C.; Richter, Jan; Yang, Yunbo; Hoefler, Michael; Weber, Heike; Reif, Andreas; Hamm, Alfons; Pane-Farre, Christiane A.; Gerlach, Alexander L.; Stroehle, Andreas; Pfleiderer, Bettina; Arolt, Volker; Wittchen, Hans-Ulrich; Gloster, Andrew; Lang, Thomas; Helbig-Lang, Sylvia; Fehm, Lydia; Pauli, Paul; Kircher, Tilo; Lueken, Ulrike and Straube, Benjamin (2019): Association of rs7688285 allelic variation coding for GLRB with fear reactivity and exposure-based therapy in patients with panic disorder and agoraphobia. In: European Neuropsychopharmacology, Vol. 29, No. 10: pp. 1138-1151

Full text not available from 'Open Access LMU'.

Abstract

The gene coding for glycine receptor beta subunits (GLRB) has been found to be related to panic disorder and agoraphobia (PD/AG) and to be associated with altered insular BOLD activation during fear conditioning, as an intermediate phenotype of defensive system reactivity in healthy subjects. In a multicenter clinical trial on PD/AG patients we investigated in three sub-samples whether GLRB allelic variation (A/G;A-allele identified as "risk") in the single nucleotide polymorphism rs7688285 was associated with autonomic (behavioral avoidance test BAT;n = 267 patients) and neural (differential fear conditioning;n = 49 patients, n = 38 controls) measures, and furthermore with responding towards exposure-based cognitive behavioral therapy (CBT, n = 184 patients). An interaction of genotype with current PD/AG diagnosis (PD/AG vs. controls;fMRI data only) and their modification after CBT was tested as well. Exploratory fMRI results prior to CBT, revealed A-allele carriers irrespective of diagnostic status to show overall higher BOLD activation in the hippocampus, motor cortex (MC) and insula. Differential activation in the MC, anterior cingulate cortex (ACC) and insula was found in the interaction genotype X diagnosis. Differential activation in ACC and hippocampus was present in differential fear learning. ACC activation was modified after treatment, while no overall rs7688285 dependent effect on clinical outcomes was found. On the behavioral level, A-allele carriers showed pronounced fear reactivity prior to CBT which partially normalized afterwards. In sum, rs7688285 variation interacts in a complex manner with PD/AG on a functional systems level and might be involved in the development of PD/AG but not in their treatment. (C) 2019 Elsevier B.V. and ECNP. All rights reserved.

Actions (login required)

View Item View Item